Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome-Reference-Cited by-同舟云学术

Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome

Published:2019-03-14 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Manganelli Valeria,Truglia Simona,Capozzi Antonella,Alessandri Cristiano,Riitano Gloria,Spinelli Francesca Romana,Ceccarelli Fulvia,Mancuso Silvia,Garofalo Tina,Longo Agostina,Valesini Guido,Sorice Maurizio,Conti Fabrizio,Misasi Roberta

Funder

Sapienza Università di Roma

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference50 articles.

1. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS);Miyakis;J Thromb Haemost.,2006

2. Antiphospholipid syndrome;Cervera;Thromb Res,2017

3. Primary antiphospholipid syndrome and antiphospholipid syndrome associated to systemic lupus: are they different entities?;Belizna;Autoimmun Rev.,2018

4. Role of infectious diseases in the antiphospholipid syndrome (including its catastrophic variant);Mendoza-Pinto;Curr Rheumatol Rep.,2018

5. Chlorpromazine-associated antiphospholipid antibody syndrome;Iyer;Ann Pharmacother.,2007

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stretch Causes cffDNA and HMGB1-Mediated Inflammation and Cellular Stress in Human Fetal Membranes;International Journal of Molecular Sciences;2024-05-09

2. Efferocytosis by macrophages in physiological and pathological conditions: regulatory pathways and molecular mechanisms;Frontiers in Immunology;2024-05-08

3. Serum Advanced Glycation End Products and Their Soluble Receptor as New Biomarkers in Systemic Lupus Erythematosus;Biomedicines;2024-03-07

4. The role of monocytes in thrombotic diseases: a review;Frontiers in Cardiovascular Medicine;2023-06-02

5. Targeting thromboinflammation in antiphospholipid syndrome;Journal of Thrombosis and Haemostasis;2023-04